Publications

Practical Considerations Shaping Pneumococcal Vaccine Selection: A Multinational Cross-Sectional Survey of Healthcare Professionals

Infectious Diseases and Therapy, Aug 2026. DOI 10.1007/s40121-026-01436-y

IPSOS US. Authors: Jeffrey T Vietri, Sophie A Warren, Matthew J Heffler (IPSOS US)

Real-World Healthcare Resource Utilization and Costs in Urethral Stricture Patients Treated with Paclitaxel-Coated Balloon (Optilume®) vs. Urethroplasty: A US Claims Analysis

WSAUA SurgeWest 2026 (poster, accepted), 25 Oct 2026

Real-world Healthcare Costs and Resource Utilization Associated with Paclitaxel-Coated Balloon vs. Urethroplasty for Urethral Stricture: A US Claims Analysis

ISPOR Europe 2026 (poster, accepted)

Real-time in-season monitoring of adult influenza vaccination coverage rates in Germany: results from a repeated cross-sectional online survey

Vaccine. 2026;88:128765. doi: 10.1016/j.vaccine.2026.128765.

Social Media Conversations on GLP-1 Therapies for Obesity: Real-World Experiences and Treatment Narratives

at ISPOR, 17-20 May – 2026, Philadelphia, USA

Social Media Sentiment Toward Anti-Amyloid Therapies in Early Alzheimer’s Disease: Implications for Real-World Evidence and Decision-Making

at ISPOR, 17-20 May – 2026, Philadelphia, USA

An Automated Social Media Listening Analysis of Conversations on CGRP Preventive Therapies in Migraine

at ISPOR, 17-20 May – 2026, Philadelphia, USA

Social Media Conversations on Immune Checkpoint Inhibitors: Treatment Experiences, Safety, Access, and Patient Perspectives

at ISPOR, 17-20 May – 2026, Philadelphia, USA

Real-World Online Conversations on MASH/NASH: A One-Year Social Media Listening Analysis

at ISPOR, 17-20 May – 2026, Philadelphia, USA

Real-World Access and Affordability Barriers in Anal Cancer: Insights From a 5-Year Global Social Media Listening Study

at AMCP, 13–16 April – 2026, Nashville, USA

Performance evaluation of an adalimumab biosimilar autoinjector and its reference device: comparative use human factors study in patients with rheumatoid arthritis and juvenile idiopathic arthritis.

Comparative Study Drug Deliv 2026: 31;33(1):2649991.

Social Media Discussions of Probiotic Use in Irritable Bowel Syndrome (IBS): Real-World Use Patterns and Patient-Reported Experiences

at World EPA Congress, 3-4 March, 2026, Amsterdam, Europe

Sociocultural and educational determinants of delayed diagnosis in anal cancer: Insights from a 5-year global social media analysis.

J Clin Oncol 44, 7(2026)

Optimizing Continuous Glucose Monitoring Adoption in India: From Current Challenges to Future Solutions

Diabetes Ther. 2026 Feb 2.

Safety profile of Semaglutide in Obesity Management With or Without Type 2 Diabetes: A Systematic Literature Review from Controlled and Real-World Settings

at ISPOR Europe 2025, 9-12 Nov’ 2025, Scotland, Glasgow

Procalcitonin-Guided Antimicrobial Stewardship for Sepsis and Lower Respiratory Tract Infections: A Budget Impact Analysis for the Perspective of the Patients in India

EE617. Volume 28, Issue 12, Supplement 1, S231, December 2025.

Economic Burden of Chronic Obstructive Pulmonary Disease (COPD) in India: A Systematic Literature Review

at ISPOR Europe 2025, 9-12 Nov’ 2025, Scotland, Glasgow

Cardiovascular Effects of Semaglutide in Patients with Obesity, With or Without Type 2 Diabetes (T2DM): An Umbrella Review

at ISPOR Europe 2025, 9-12 Nov’ 2025, Scotland, Glasgow

Tracing the Shift in Payer Evidence Expectations: A Review of AMCP Format Updates (2016-2024)

at ISPOR Europe 2025, 9-12 Nov’ 2025, Scotland, Glasgow

Economic Burden of Systemic Lupus Erythematosus (SLE) Among Women in the USA: A Systematic Review

at ISPOR Europe 2025, 9-12 Nov’ 2025, Scotland, Glasgow

Research Trends in Rare Diseases in Real-World Settings in Europe: A Scoping Review (2013–2023)

at WODC 2025, 27-29 Oct’ 2025, Amsterdam, Europe

Economic Burden of Systemic Lupus Erythematosus (SLE) among Women from India: a Scoping Review

at Lupus 2025, 21-24 May, 2025, Toronto, Canada

at World EPA Congress, 5-6 March, 2025, Amsterdam, Europe

Effectiveness and Safety of Glycopyrronium-Formoterol-Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study.

Adv Respir Med. 2025.

Added Value of Nucleic Acid Testing in Blood Banks: A 15-Year Retrospective Study from India

Cureus 17(12): e98684. doi:10.7759/cureus.98684